Skip to main content
Erschienen in: Acta Diabetologica 1/2015

01.02.2015 | Original Article

Levels of adiponectin and leptin at onset of type 1 diabetes have changed over time in children and adolescents

verfasst von: Narges Safai, Stefanie Eising, David Michael Hougaard, Henrik Bindesbøl Mortensen, Kristin Skogstrand, Flemming Pociot, Jesper Johannesen, Jannet Svensson

Erschienen in: Acta Diabetologica | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Adiponectin and leptin are proteins secreted by the adipose tissue and have an influence on insulin sensitivity and on inflammatory markers. Altered levels could play a part in the pathogenesis of type 1 diabetes mellitus. We determined adiponectin and leptin levels over a nine-year period in children with type 1 diabetes mellitus (T1D) in relation to the increasing incidence of T1D, and studied the impact of patient status, age, gender and body mass index (BMI). Data were derived from a population-based registry of diabetic children (DanDiabKids) from 1997 to 2005. Children with newly diagnosed T1D (n = 482) were included, and healthy siblings (n = 479) were chosen as a control group. Leptin levels were significantly higher in recent years (in both patients and siblings), whereas for adiponectin, the levels were lower in recent years in the patient group. Leptin levels were lower in children with T1D (RR 0.74, p = 0.003) and in males (RR 0.52, p < 0.001) and increasing with age in both groups. For adiponectin, there was a negative association between level and age in patients. Both adipokines showed a significant correlation with BMI and lower levels in children with blood samples taken within the first 2 days after initiation of insulin treatment. There has been a change in leptin and adiponectin levels in children with or without T1D from 1997 to 2005. This is not explained by changes in BMI and may reflect changes in other factors like diet or physical activity.
Literatur
1.
Zurück zum Zitat Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of Type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42(12):1395–1403. doi:10.1007/s001250051309 PubMedCrossRef Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of Type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42(12):1395–1403. doi:10.​1007/​s001250051309 PubMedCrossRef
2.
Zurück zum Zitat Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83PubMedCrossRef Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83PubMedCrossRef
10.
Zurück zum Zitat Svensson J, Eising S, Hougaard DM, Mortensen HB, Skogstrand K, Simonsen LB, Carstensen B, Nilsson A, Lernmark A, Pociot F, Johannesen J (2012) Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings. Hum Immunol 73(11):1116–1126. doi:10.1016/j.humimm.2012.07.337 PubMedCrossRef Svensson J, Eising S, Hougaard DM, Mortensen HB, Skogstrand K, Simonsen LB, Carstensen B, Nilsson A, Lernmark A, Pociot F, Johannesen J (2012) Few differences in cytokines between patients newly diagnosed with type 1 diabetes and their healthy siblings. Hum Immunol 73(11):1116–1126. doi:10.​1016/​j.​humimm.​2012.​07.​337 PubMedCrossRef
11.
Zurück zum Zitat Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark A, Pociot F (2011) Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 44(2):107–114. doi:10.3109/08916934.2010.509120 PubMedCrossRef Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark A, Pociot F (2011) Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 44(2):107–114. doi:10.​3109/​08916934.​2010.​509120 PubMedCrossRef
12.
Zurück zum Zitat Nysom K, Molgaard C, Michaelsen KF, Hutchings B, Andersen E (2002) Body mass index. Reference values for 0–45-year-old Danes. Ugeskr Laeger 164(49):5773–5777PubMed Nysom K, Molgaard C, Michaelsen KF, Hutchings B, Andersen E (2002) Body mass index. Reference values for 0–45-year-old Danes. Ugeskr Laeger 164(49):5773–5777PubMed
13.
Zurück zum Zitat Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51(10):1854–1866. doi:10.1373/clinchem.2005.052241 PubMedCrossRef Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51(10):1854–1866. doi:10.​1373/​clinchem.​2005.​052241 PubMedCrossRef
14.
Zurück zum Zitat Nielsen LB, Vaziri-Sani F, Porksen S, Andersen ML, Svensson J, Bergholdt R, Pociot F, Hougaard P, de Beaufort C, Castano L, Mortensen HB, Lernmark A, Hansen L (2011) Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 44(8):616–623. doi:10.3109/08916934.2011.576724 PubMedCrossRef Nielsen LB, Vaziri-Sani F, Porksen S, Andersen ML, Svensson J, Bergholdt R, Pociot F, Hougaard P, de Beaufort C, Castano L, Mortensen HB, Lernmark A, Hansen L (2011) Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes. Autoimmunity 44(8):616–623. doi:10.​3109/​08916934.​2011.​576724 PubMedCrossRef
15.
Zurück zum Zitat Rolland-Cachera MF, Castetbon K, Arnault N, Bellisle F, Romano MC, Lehingue Y, Frelut ML, Hercberg S (2002) Body mass index in 7–9-y-old French children: frequency of obesity, overweight and thinness. Int J Obes Relat Metab Disord 26(12):1610–1616. doi:10.1038/sj.ijo.0802146 PubMedCrossRef Rolland-Cachera MF, Castetbon K, Arnault N, Bellisle F, Romano MC, Lehingue Y, Frelut ML, Hercberg S (2002) Body mass index in 7–9-y-old French children: frequency of obesity, overweight and thinness. Int J Obes Relat Metab Disord 26(12):1610–1616. doi:10.​1038/​sj.​ijo.​0802146 PubMedCrossRef
18.
Zurück zum Zitat Zimmermann MB, Gubeli C, Puntener C, Molinari L (2004) Detection of overweight and obesity in a national sample of 6–12-y-old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Prevention and the International Obesity Task Force. Am J Clin Nutr 79(5):838–843PubMed Zimmermann MB, Gubeli C, Puntener C, Molinari L (2004) Detection of overweight and obesity in a national sample of 6–12-y-old Swiss children: accuracy and validity of reference values for body mass index from the US Centers for Disease Control and Prevention and the International Obesity Task Force. Am J Clin Nutr 79(5):838–843PubMed
19.
Zurück zum Zitat Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 288(14):1728–1732PubMedCrossRef Ogden CL, Flegal KM, Carroll MD, Johnson CL (2002) Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 288(14):1728–1732PubMedCrossRef
21.
Zurück zum Zitat Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A (2006) Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 23(6):660–665. doi:10.1111/j.1464-5491.2006.01823.x PubMedCrossRef Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, Mencacci M, Berioli MG, De Giorgi G, Falorni A (2006) Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabet Med 23(6):660–665. doi:10.​1111/​j.​1464-5491.​2006.​01823.​x PubMedCrossRef
22.
Zurück zum Zitat Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M (2004) Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 27(8):2010–2014PubMedCrossRef Morales A, Wasserfall C, Brusko T, Carter C, Schatz D, Silverstein J, Ellis T, Atkinson M (2004) Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes. Diabetes Care 27(8):2010–2014PubMedCrossRef
23.
Zurück zum Zitat Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB (2001) Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 86(3):1188–1193PubMedCrossRef Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB (2001) Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 86(3):1188–1193PubMedCrossRef
24.
Zurück zum Zitat Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W (2007) Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol 157(4):481–489. doi:10.1530/EJE-07-0250 PubMedCrossRef Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W (2007) Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol 157(4):481–489. doi:10.​1530/​EJE-07-0250 PubMedCrossRef
25.
27.
Zurück zum Zitat Sartorius T, Heni M, Tschritter O, Preissl H, Hopp S, Fritsche A, Lievertz PS, Gertler A, Berthou F, Taouis M, Staiger H, Haring HU, Hennige AM (2012) Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity. Cell Physiol Biochem 30(1):238–246. doi:10.1159/000339060 PubMedCrossRef Sartorius T, Heni M, Tschritter O, Preissl H, Hopp S, Fritsche A, Lievertz PS, Gertler A, Berthou F, Taouis M, Staiger H, Haring HU, Hennige AM (2012) Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity. Cell Physiol Biochem 30(1):238–246. doi:10.​1159/​000339060 PubMedCrossRef
28.
Zurück zum Zitat Tjonna AE, Stolen TO, Bye A, Volden M, Slordahl SA, Odegard R, Skogvoll E, Wisloff U (2009) Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci (Lond) 116(4):317–326. doi:10.1042/CS20080249 CrossRef Tjonna AE, Stolen TO, Bye A, Volden M, Slordahl SA, Odegard R, Skogvoll E, Wisloff U (2009) Aerobic interval training reduces cardiovascular risk factors more than a multitreatment approach in overweight adolescents. Clin Sci (Lond) 116(4):317–326. doi:10.​1042/​CS20080249 CrossRef
31.
Zurück zum Zitat Murakami K, Sasaki S, Takahashi Y, Uenishi K, Yamasaki M, Hayabuchi H, Goda T, Oka J, Baba K, Ohki K, Watanabe R, Sugiyama Y (2007) Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition 23(6):461–468. doi:10.1016/j.nut.2007.04.006 PubMedCrossRef Murakami K, Sasaki S, Takahashi Y, Uenishi K, Yamasaki M, Hayabuchi H, Goda T, Oka J, Baba K, Ohki K, Watanabe R, Sugiyama Y (2007) Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition 23(6):461–468. doi:10.​1016/​j.​nut.​2007.​04.​006 PubMedCrossRef
33.
Zurück zum Zitat Kirel B, Dogruel N, Korkmaz U, Kilic FS, Ozdamar K, Ucar B (2000) Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels. Clin Biochem 33(6):475–480PubMedCrossRef Kirel B, Dogruel N, Korkmaz U, Kilic FS, Ozdamar K, Ucar B (2000) Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels. Clin Biochem 33(6):475–480PubMedCrossRef
34.
Zurück zum Zitat Martos-Moreno GA, Barrios V, Soriano-Guillen L, Argente J (2006) Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur J Endocrinol 155(5):757–761. doi:10.1530/eje.1.02273 PubMedCrossRef Martos-Moreno GA, Barrios V, Soriano-Guillen L, Argente J (2006) Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur J Endocrinol 155(5):757–761. doi:10.​1530/​eje.​1.​02273 PubMedCrossRef
35.
Zurück zum Zitat Hanaki K, Becker DJ, Arslanian SA (1999) Leptin before and after insulin therapy in children with new-onset type 1 diabetes. J Clin Endocrinol Metabolism 84(5):1524–1526 Hanaki K, Becker DJ, Arslanian SA (1999) Leptin before and after insulin therapy in children with new-onset type 1 diabetes. J Clin Endocrinol Metabolism 84(5):1524–1526
36.
Zurück zum Zitat McCormick KL, Mick GJ, Butterfield L, Ross H, Parton E, Totka J (2001) Leptin in children with newly diagnosed type 1 diabetes: effect of insulin therapy. Int J Exp Diabetes Res 2(2):121–127PubMedCentralPubMedCrossRef McCormick KL, Mick GJ, Butterfield L, Ross H, Parton E, Totka J (2001) Leptin in children with newly diagnosed type 1 diabetes: effect of insulin therapy. Int J Exp Diabetes Res 2(2):121–127PubMedCentralPubMedCrossRef
38.
39.
Zurück zum Zitat Kratzsch J, Knerr I, Galler A, Kapellen T, Raile K, Korner A, Thiery J, Dotsch J, Kiess W (2006) Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur J Endocrinol 155(4):609–614. doi:10.1530/eje.1.02261 PubMedCrossRef Kratzsch J, Knerr I, Galler A, Kapellen T, Raile K, Korner A, Thiery J, Dotsch J, Kiess W (2006) Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur J Endocrinol 155(4):609–614. doi:10.​1530/​eje.​1.​02261 PubMedCrossRef
40.
Zurück zum Zitat Kaas A, Pfleger C, Hansen L, Buschard K, Schloot NC, Roep BO, Mortensen HB (2010) Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis. Clin Exp Immunol 161(3):444–452. doi:10.1111/j.1365-2249.2010.04193.x PubMedCentralPubMedCrossRef Kaas A, Pfleger C, Hansen L, Buschard K, Schloot NC, Roep BO, Mortensen HB (2010) Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis. Clin Exp Immunol 161(3):444–452. doi:10.​1111/​j.​1365-2249.​2010.​04193.​x PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89(8):4053–4061. doi:10.1210/jc.2004-0303 PubMedCrossRef Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89(8):4053–4061. doi:10.​1210/​jc.​2004-0303 PubMedCrossRef
Metadaten
Titel
Levels of adiponectin and leptin at onset of type 1 diabetes have changed over time in children and adolescents
verfasst von
Narges Safai
Stefanie Eising
David Michael Hougaard
Henrik Bindesbøl Mortensen
Kristin Skogstrand
Flemming Pociot
Jesper Johannesen
Jannet Svensson
Publikationsdatum
01.02.2015
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 1/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0630-y

Weitere Artikel der Ausgabe 1/2015

Acta Diabetologica 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.